APA (7th ed.) Citation

JS, A., JY, H., JO, P., SY, L., S, K., HY, Y., . . . HY, L. (2025). Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors. Cancer research and treatment. https://doi.org/10.4143/crt.2025.820

Chicago Style (17th ed.) Citation

JS, Ahn, et al. "Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors." Cancer Research and Treatment 2025. https://doi.org/10.4143/crt.2025.820.

MLA (9th ed.) Citation

JS, Ahn, et al. "Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors." Cancer Research and Treatment, 2025, https://doi.org/10.4143/crt.2025.820.